Immuron (FRA:ANW) Change In Inventory : €0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Immuron Change In Inventory?

Immuron's change in inventory for the quarter that ended in Dec. 2023 was €0.00 Mil. It means Immuron's inventory stayed the same from Jun. 2023 to Dec. 2023 .

Immuron's change in inventory for the fiscal year that ended in Jun. 2023 was €0.00 Mil. It means Immuron's inventory stayed the same from Jun. 2022 to Jun. 2023 .

Immuron's Total Inventories for the quarter that ended in Dec. 2023 was €0.99 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Immuron's Days Inventory for the quarter that ended in Dec. 2023 was 290.24.

Inventory Turnover measures how fast the company turns over its inventory within a year. Immuron's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.63.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Immuron's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.52.

Immuron Change In Inventory Historical Data

The historical data trend for Immuron's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immuron Change In Inventory Chart

Immuron Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Change In Inventory

Get a 7-Day Free Trial

Immuron Semi-Annual Data
	Jun15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Inventory	Get a 7-Day Free Trial												-	-	-	-	-

Immuron Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Immuron (FRA:ANW) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Immuron's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.757	/	0.476	*	365 / 2
	=	290.24

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Immuron's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.476	/	0.757
	=	0.63

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Immuron's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.757	/	1.446
	=	0.52

Immuron Change In Inventory Related Terms

Thank you for viewing the detailed overview of Immuron's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Immuron (FRA:ANW) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuron Ltd (FRA:ANW) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

IMRN:USA ANWA:Germany IMC:Australia

Address

Chapman Street, Unit 10, 25-37, Blackburn North, Melbourne, VIC, AUS, 3130

Website

https://www.immuron.com.au

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

Immuron (FRA:ANW) Headlines

No Headlines